Published 1996 | Version v1
Journal article

Hypopharyngeal carcinoma: King Faisal Specialist Hospital and Research Center experience

  • 1. Dept. of Surgery, King Faisal Specialist Hospital and Research Center, Riyadh (Saudi Arabia)
  • 2. Dept. of Biomedical Statistics and Scientific Computing, King Faisal Specialist Hospital and Research Center, Riyadh (Saudi Arabia)

Description

From 1975 to 1985, 202 patients with hypopharyngeal cancer were seen at King Faisal Specialist Hospital and Research Center (KFSHRC). The endoscopic investigation showed that 28.3% of these patients had postcricoid carcinoma; 19.85% had pyriform fossa carcinoma and 52.9% had involvement of both sites. The pathological diagnosis of all cases was squamous cell carcinoma type. The majority of the patients (62.98%) had T4 lesions, which showed a late presentation to KFSHRC. Information related to survival was available for a smaller number of patients to many lost-to-follow-up cases. The overall median survival time was 8.5 months (1-110 months). The survival rate for each site was calculated, as well as the staging of the disease and treatment modality used. It appeared that pyriform fossa (median 21 months) had the best survival rate. In addition the earlier the lesion was detected and the more aggressive the treatment applied, the better the survival rate. Fifty percent of the patients receiving radiation therapy and surgery had a five year survival arte. Factors other than smoking and/on drinking should be looked for in our community as predisposing to this disease in our population. (author)

Additional details

Publishing Information

Journal Title
Annals of Saudi Medicine
Journal Volume
16
Journal Issue
5
Journal Page Range
p. 539-544
ISSN
0256-4947

INIS

Country of Publication
Saudi Arabia
Country of Input or Organization
Saudi Arabia
INIS RN
40030318
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; CHEMOTHERAPY; DISEASES; LARYNX; PATIENTS; SAUDI ARABIA; SURGERY
Descriptors DEC
ARAB COUNTRIES; ASIA; DEVELOPING COUNTRIES; DISEASES; MEDICINE; MIDDLE EAST; NEOPLASMS; RESPIRATORY SYSTEM; THERAPY